Opioid-Induced Constipation Pipeline Review: Efforts to Reduce Side-Effects of Opioids Gaining Traction

Published on : Feb 15, 2018

Albany, New York, February 15, 2018: A new research study analyzing the pipeline of opioid induced constipation (OIC) has been added to the vast repository of Market Research Hub (MRH). The report titled “Opioid-Induced Constipation (OIC)-Pipeline Review, H1 2018” is a comprehensive source of information that reviews the drugs under different stages of development by both companies and universities.

The report discusses the therapeutic approaches currently underway in developing effective opioid induced constipation drugs. Opioids have remained an integral component of chronic management, however, their range of side effects have posed challenges to their widespread adoption. Among the various side effects of prolonged use of opioids, opioid induced constipation has been reported by a large number of people. Opioid induced constipation reduces the quality of life of patients and leads to a range of health issues. According to the report, it is in the backdrop of these factors that developing effective treatment methods has gained prominence among pharmaceutical companies.

The research study on opioid-induced constipation therapeutic development offers unbiased and reliable information on the basis of molecule type, mechanism of action, different stages of development, route of administration, and drug target. The pharmacological action of the drugs has been studied, with analysis offered on the historical developments pertaining to this drug. Opioid-induced constipation therapeutics developed by companies, institutes, and universities have been included in the report. The molecules developed by companies, institutes, and universities under various stages of development such as pre-registration, phase II, and phase III are analyzed in the report.

In addition to analyzing the various therapeutic drugs under development, the report also offers a detailed profiling of the key players operating in the market. The business and product strategies of the leading players in the market has been analyzed, and a holistic assessment has been offered to the readers for their perusal. Stakeholders in the market can gain a wealth of critical insights about the strategies of new entrants. The intelligence offered in the report can also contribute to the development of effective counter-strategies through which stakeholders can gain an edge over their competitors. The study has been compiled after thorough primary and secondary research, with decision-makers across the spectrum offering their insights on the key developments in this landscape. Prominent sources of secondary research include company announcements, media briefings, and press releases. Overall, the report offers a holistic and comprehensive review of the opioid-induced constipation therapeutic landscape, with information on the upcoming drugs in the market.

Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1532628

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top